VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACAArcosa, Inc.
$145.29$7.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACAP/E History

ACA logoArcosa, Inc. (ACA) P/E Ratio History

Expensive

Trading at 34.3x vs 5Y avg 29.6x · 60th percentile · Material premium to history · Data 2018–2026

Current P/E (TTM)
34.3x
+16% vs 5Y avg
5Y Avg P/E
29.6x
Median 29.4x
5Y Percentile
60th
Mid-range
PEG Ratio
2.41
Premium to growth
5-Year P/E Range
34.3x
Min10.8xMedian29.4xMax50.6x
TTM EPS$4.52
Price$145.29
Earnings Yield2.92%
EPS Growth (1Y)122.0%
EPS Growth (5Y)14.2%

Loading P/E history...

P/E Ratio Analysis

As of July 1, 2026, Arcosa, Inc. (ACA) trades at a price-to-earnings ratio of 34.3x, with a stock price of $145.29 and trailing twelve-month earnings per share of $4.52.

The current P/E is 16% above its 5-year average of 29.6x. Over the past five years, ACA's P/E has ranged from a low of 10.8x to a high of 50.6x, placing the current valuation at the 60th percentile of its historical range.

Compared to the Industrials sector median P/E of 26.1x, ACA trades at a 31% premium to its sector peers. The sector includes 400 companies with P/E ratios ranging from 0.0x to 197.3x.

The PEG ratio of 2.41 (P/E divided by 122% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, ACA commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ACA DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

ACA Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Industrials
34.3vs26.1
+31%
Above Sector
vs. S&P 500
34.3vs25.1
+37%
Above Market
PEG Analysis
2.41
P/E ÷ EPS Growth
PEG > 2 = Expensive
Based on 122% EPS growth (1Y)

ACA P/E vs Peers

Infrastructure Products Manufacturing peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
MLM logoMLMMartin Marietta Materials, Inc.
$35B30.72.99-42%
VMC logoVMCVulcan Materials Company
$38B36.32.78+19%
CRH logoCRHCRH plc
$71B19.40.62+10%
TRN logoTRNTrinity Industries, Inc.
$3B11.3-+86%
RAIL logoRAILFreightCar America, Inc.
$310M8.9-+135%Best
GBX logoGBXThe Greenbrier Companies, Inc.
$2B7.7Lowest0.23Best+28%
AAON logoAAONAAON, Inc.
$10B98.318.09-36%
TREX logoTREXTrex Company, Inc.
$5B28.18.40-15%
NUE logoNUENucor Corporation
$51B29.61.14-11%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

ACA Historical P/E Data (2018–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$106.14$4.0626.1x-1%
FY2025 Q4Dec 31 2025$106.32$4.2425.1x-5%
FY2025 Q3-$93.71$3.0231.0x+17%
FY2025 Q2Jun 30 2025$86.71$1.8846.1x+74%
FY2025 Q1Mar 31 2025$77.12$1.5948.5x+83%
FY2024 Q4-$96.74$1.9150.6x+91%
FY2024 Q3Sep 30 2024$94.76$2.6236.2x+37%
FY2024 Q2Jun 30 2024$83.41$3.0127.7x+5%
FY2024 Q1Mar 31 2024$85.86$2.9229.4x+11%
FY2023 Q4Dec 31 2023$82.64$3.2625.3x-4%
FY2023 Q3Sep 30 2023$71.90$5.8912.2x-54%
FY2023 Q2Jun 30 2023$75.77$5.8213.0x-51%
FY2023 Q1Mar 31 2023$63.11$5.7810.9x-59%
FY2022 Q4Dec 31 2022$54.34$5.0510.8x-59%
FY2022 Q3Sep 30 2022$57.18$2.0627.8x+5%
FY2022 Q2-$46.43$1.8924.6x-7%
FY2022 Q1-$57.25$1.5237.7x+42%
FY2021 Q4Dec 31 2021$52.70$1.4336.9x+39%
FY2021 Q3-$50.17$1.4534.6x+31%
FY2021 Q2Jun 30 2021$58.74$1.6036.7x+39%
FY2021 Q1Mar 31 2021$65.09$1.8535.2x+33%
FY2020 Q4-$54.93$2.1825.2x-5%
FY2020 Q3Sep 30 2020$44.09$2.4018.4x-31%
FY2020 Q2-$42.20$2.4317.4x-34%
FY2020 Q1-$39.74$2.4016.6x-37%
FY2019 Q4-$44.55$2.3119.3x-27%
FY2019 Q3Sep 30 2019$34.21$2.4414.0x-47%
FY2019 Q2Jun 30 2019$37.63$1.8420.5x-23%
FY2019 Q1Mar 31 2019$30.55$1.6518.6x-30%
FY2018 Q4Dec 31 2018$27.69$1.5418.0x-32%

Average P/E for displayed period: 26.5x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ACA — Frequently Asked Questions

Quick answers to the most common questions about buying ACA stock.

What is ACA's P/E ratio?

Arcosa, Inc. (ACA) trailing twelve-month P/E ratio is 34.3x, based on TTM diluted EPS of $4.52. The 5-year average P/E is 29.6x and the historical range spans 10.8x to 50.6x.

Is ACA stock overvalued or undervalued?

ACA trades at 34.3x P/E, near its 5-year average of 29.6x. The 60th percentile ranking within the 10.8x–50.6x historical range places valuation within normal bounds.

Is ACA stock expensive?

ACA is fairly valued relative to its own history. The current P/E of 34.3x is near the 5-year average of 29.6x (60th percentile of historical range).

What is ACA's historical P/E range?

Over the past 5 years, ACA's P/E ratio has ranged from 10.8x to 50.6x, with a median of 29.4x and an average of 29.6x. The current P/E of 34.3x places the stock at the 60th percentile of this range. Full historical data spans 2018–2026.

How does ACA's P/E compare to the S&P 500?

ACA trades at 34.3x P/E versus the S&P 500 median of 25.1x. The 37% premium to the market typically reflects higher expected earnings growth or quality.

How does ACA's valuation compare to Industrials peers?

Arcosa, Inc. P/E of 34.3x compares to the Industrials sector median of 26.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is ACA's PEG ratio?

ACA PEG ratio is 2.41, based on a P/E of 34.3x and EPS growth of 122.0%. A PEG above 2.0 indicates a premium valuation relative to earnings growth — typically considered expensive.

What is ACA's earnings yield?

ACA earnings yield is 2.92%, the inverse of its 34.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

ACA P/E Ratio History (2018–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current26.1x
Period Avg29.6x
Range10.8x - 50.6x
Change-29%
20 quartersJun 30, 2021 - Mar 31, 2026